These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1506735)

  • 1. [Development of an experimental model for ovarian cancer invasion using cultured mesothelial cell layer].
    Sawada M; Tanizawa O; Inagaki M; Ozaki M; Shii J; Akedo H
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):725-6. PubMed ID: 1506735
    [No Abstract]   [Full Text] [Related]  

  • 2. An experimental model for ovarian tumor invasion of cultured mesothelial cell monolayer.
    Sawada M; Shii J; Akedo H; Tanizawa O
    Lab Invest; 1994 Mar; 70(3):333-8. PubMed ID: 8145527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models.
    Kishikawa T; Sakamoto M; Ino Y; Kubushiro K; Nozawa S; Hirohashi S
    Invasion Metastasis; 1995; 15(1-2):11-21. PubMed ID: 7545653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelial vitronectin stimulates migration of ovarian cancer cells.
    Heyman L; Leroy-Dudal J; Fernandes J; Seyer D; Dutoit S; Carreiras F
    Cell Biol Int; 2010 Apr; 34(5):493-502. PubMed ID: 20121701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human ovarian epithelial adenocarcinoma with peritoneal metastasis and ascites established in murine models].
    Li WJ; Qian HN
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jan; 28(1):38-40, 61. PubMed ID: 8504709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
    Huang JS
    Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel screening technique for dissemination potential of ovarian cancer cells to peritoneum.
    Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
    Invasion Metastasis; 1996; 16(6):302-7. PubMed ID: 9371229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D.
    Imamura F; Horai T; Mukai M; Shinkai K; Sawada M; Akedo H
    Biochem Biophys Res Commun; 1993 Jun; 193(2):497-503. PubMed ID: 8390242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of immunohistochemical staining of human cultured mesothelial cells and ovarian tumour cells using epithelial and mesothelial cell markers.
    Radford H; Wilson AP
    Anal Cell Pathol; 1996 Aug; 11(3):173-82. PubMed ID: 8888953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current issues in the pathology of ovarian cancer.
    Rabban JT; Bell DA
    J Reprod Med; 2005 Jun; 50(6):467-74. PubMed ID: 16050571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.
    Shibata K; Kikkawa F; Nawa A; Suganuma N; Hamaguchi M
    Cancer Res; 1997 Dec; 57(23):5416-20. PubMed ID: 9393769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.
    Rodriguez GC; Haisley C; Hurteau J; Moser TL; Whitaker R; Bast RC; Stack MS
    Gynecol Oncol; 2001 Feb; 80(2):245-53. PubMed ID: 11161867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphology of the growth of heterotransplants of human ovarian cancer in diffusion chambers].
    Sobol' IL
    Biull Eksp Biol Med; 1980 Jul; 89(7):121-3. PubMed ID: 7407362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.
    Slack-Davis JK; Atkins KA; Harrer C; Hershey ED; Conaway M
    Cancer Res; 2009 Feb; 69(4):1469-76. PubMed ID: 19208843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role and prognostic significance of CD157 in ovarian carcinoma.
    Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
    J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
    Chambers SK; Wang Y; Gertz RE; Kacinski BM
    Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a liver metastatic model of human ovarian cancer.
    Yoshida Y; Kamitani N; Sasaki H; Kusumi K; Tominaga T; Kotsuji F
    Anticancer Res; 1998; 18(1A):327-31. PubMed ID: 9568098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C; Bergeron C; Lane D; Garon G; Piché A
    Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.